Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 41 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

Recent advances in dementia research have expanded our understanding of modifiable risk factors, with air pollution being a well-established contributor. However, microplastics-plastic particles smaller than 5 mm-represent an understudied component of environmental pollution that may significantly impact neurological health. This review examines emerging evidence linking chronic microplastic exposure to increased dementia risk. Microplastics enter the human body through multiple routes, including ingestion of contaminated food and water, inhalation, and dermal absorption, with demonstrated ability to cross the blood-brain barrier and initiate several pathogenic pathways. Four primary mechanisms appear to mediate microplastic-induced neurodegeneration: increased oxidative stress through reactive oxygen species (ROS) production; neuroinflammation via microglial activation and chronic inflammatory responses; neurotoxicity from transported persistent organic pollutants (POPs) and heavy metals; and accelerated amyloid-beta pathology through enhanced Aβ40 and Aβ42 nucleation. Recent bioaccumulation studies have revealed significantly elevated microplastic concentrations in the brains of dementia patients compared to non-dementia controls, supporting a potential dose-dependent relationship. Sources of environmental microplastics include industrial waste, synthetic textiles, plastic degradation products, and tire wear particles, creating a ubiquitous exposure risk through contaminated air, food, and water. While preliminary evidence supports a mechanistic link between microplastics and neurodegeneration, comprehensive epidemiological studies with larger datasets are needed to quantify this relationship and establish dose-response patterns. Future research should focus on identifying which microplastic types pose the greatest neurological risks, determining threshold exposure levels, and developing interventions to mitigate exposure.

Key findings

Why it matters

This review proposes chronic microplastic exposure as a possible new risk factor for dementia, describing mechanisms such as oxidative stress, neuroinflammation, and accelerated amyloid-beta pathology, and notes higher microplastic concentrations in the brains of dementia patients than controls. It is a review of emerging evidence and does not show that reducing microplastic exposure prevents or treats Alzheimer's disease.

Study details

How this study scored 41/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 3 of 7; Citations per year 3 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 2 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 41 of 100.41 of 100 points earned59 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Frontiers in Neurology)
Journal's citation record 2 / 4 Frontiers in Neurology: journal h-index 162 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 3 / 7 Cited 33 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 11.0 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 7.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 2 / 4 Cited 33 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Burcu Balam Doğu: h-index 33 (OpenAlex, whole career)
Institution's track record 0 / 3 Hacettepe University: institution h-index 410 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40520605)
Free to read 2 / 2 Free to read
Total 41 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Gecegelen, E., Üçdal, M. T., & Doğu, B. B. (2025). A novel risk factor for dementia: chronic microplastic exposure. Frontiers in Neurology. https://doi.org/10.3389/fneur.2025.1581109

Vancouver

Gecegelen E, Üçdal MT, Doğu BB. A novel risk factor for dementia: chronic microplastic exposure. Frontiers in Neurology. 2025. doi:10.3389/fneur.2025.1581109. PMID: 40520605.

BibTeX

@article{gecegelen2025-40520605,
  author  = {Gecegelen, Elif and Üçdal, Mete Tuğcan and Doğu, Burcu Balam},
  title   = {{A novel risk factor for dementia: chronic microplastic exposure}},
  journal = {Frontiers in Neurology},
  year    = {2025},
  doi     = {10.3389/fneur.2025.1581109},
  pmid    = {40520605},
  url     = {https://doi.org/10.3389/fneur.2025.1581109}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Digital health tools

Similar studies

More on Digital health tools

See all studies in Digital health tools →